P50 CA108786/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2005	1
2006	5
2007	10
2008	15
2009	28
2010	22
2011	29
2012	24
2013	14
2014	16
2015	13
2016	6
2017	4
2018	1
2021	0

1

IDH1 and IDH2 mutations in gliomas.

Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD. Yan H, et al. N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710. N Engl J Med. 2009. PMID: 19228619 Free PMC article.

2

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Sampson JH. Mitchell DA, et al. Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11. Nature. 2015. PMID: 25762141 Free PMC article. Clinical Trial.

3

Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.

Kurmasheva RT, Sammons M, Favours E, Wu J, Kurmashev D, Cosmopoulos K, Keilhack H, Klaus CR, Houghton PJ, Smith MA. Kurmasheva RT, et al. Pediatr Blood Cancer. 2017 Mar;64(3):10.1002/pbc.26218. doi: 10.1002/pbc.26218. Epub 2016 Aug 24. Pediatr Blood Cancer. 2017. PMID: 27555605 Free PMC article.

4

Combating immunosuppression in glioma.

Vega EA, Graner MW, Sampson JH. Vega EA, et al. Future Oncol. 2008 Jun;4(3):433-42. doi: 10.2217/14796694.4.3.433. Future Oncol. 2008. PMID: 18518768 Free PMC article. Review.

5

Urinary biomarkers of oxidative status.

Il'yasova D, Scarbrough P, Spasojevic I. Il'yasova D, et al. Clin Chim Acta. 2012 Oct 9;413(19-20):1446-53. doi: 10.1016/j.cca.2012.06.012. Epub 2012 Jun 7. Clin Chim Acta. 2012. PMID: 22683781 Free PMC article. Review.

6

New treatment strategies for malignant gliomas.

Sathornsumetee S, Rich JN. Sathornsumetee S, et al. Expert Rev Anticancer Ther. 2006 Jul;6(7):1087-104. doi: 10.1586/14737140.6.7.1087. Expert Rev Anticancer Ther. 2006. PMID: 16831080 Review.

7

The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Heimberger AB, Sampson JH. Heimberger AB, et al. Expert Opin Biol Ther. 2009 Aug;9(8):1087-98. doi: 10.1517/14712590903124346. Expert Opin Biol Ther. 2009. PMID: 19591631 Free PMC article. Review.

8

Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier.

Mehta AI, Brufsky AM, Sampson JH. Mehta AI, et al. Cancer Treat Rev. 2013 May;39(3):261-9. doi: 10.1016/j.ctrv.2012.05.006. Epub 2012 Jun 22. Cancer Treat Rev. 2013. PMID: 22727691 Free PMC article. Review.

9

Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.

Reardon DA, Wen PY, Desjardins A, Batchelor TT, Vredenburgh JJ. Reardon DA, et al. Expert Opin Biol Ther. 2008 Apr;8(4):541-53. doi: 10.1517/14712598.8.4.541. Expert Opin Biol Ther. 2008. PMID: 18352856 Free PMC article. Review.

10

Toward effective immunotherapy for the treatment of malignant brain tumors.

Mitchell DA, Sampson JH. Mitchell DA, et al. Neurotherapeutics. 2009 Jul;6(3):527-38. doi: 10.1016/j.nurt.2009.04.003. Neurotherapeutics. 2009. PMID: 19560742 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results